The results were based on votes from founder peers in the Estonian startup community, reflecting strong support within the ecosystem that we highly appreciate.

In 2025, we enrolled more than 100 patients in our DFU clinical trial, received our first European patent, and obtained certification for our Quality Management System in compliance with ISO 13485:2016. This marks an important milestone on our path toward EU and FDA approvals, which are the next planned steps.

Read more about the awards: https://www.lift99.co/blog/estonian-startup-awards-2025